Identification of Upstream Transcriptional Regulators of Ischemic Cardiomyopathy Using Cardiac RNA-Seq Meta-Analysis

Ischemic cardiomyopathy (ICM), characterized by pre-existing myocardial infarction or severe coronary artery disease, is the major cause of heart failure (HF). Identification of novel transcriptional regulators in ischemic HF can provide important biomarkers for developing new diagnostic and therapeutic strategies. In this study, we used four RNA-seq datasets from four different studies, including 41 ICM and 42 non-failing control (NF) samples of human left ventricle tissues, to perform the first RNA-seq meta-analysis in the field of clinical ICM, in order to identify important transcriptional regulators and their targeted genes involved in ICM. Our meta-analysis identified 911 differentially expressed genes (DEGs) with 582 downregulated and 329 upregulated. Interestingly, 54 new DEGs were detected only by meta-analysis but not in individual datasets. Upstream regulator analysis through Ingenuity Pathway Analysis (IPA) identified three key transcriptional regulators. TBX5 was identified as the only inhibited regulator (z-score = −2.89). F2R and SFRP4 were identified as the activated regulators (z-scores = 2.56 and 2.00, respectively). Multiple downstream genes regulated by TBX5, F2R, and SFRP4 were involved in ICM-related diseases such as HF and arrhythmia. Overall, our study is the first to perform an RNA-seq meta-analysis for clinical ICM and provides robust candidate genes, including three key transcriptional regulators, for future diagnostic and therapeutic applications in ischemic heart failure.

[1]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[2]  R. V. van Leeuwen,et al.  Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening , 2015, Circulation research.

[3]  Jun Lu,et al.  Identification of the difference in the pathogenesis in heart failure arising from different etiologies using a microarray dataset , 2017, Clinics.

[4]  E. Braunwald,et al.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. , 2017, Circulation research.

[5]  Shanshan Guo,et al.  Identification of potential genes for human ischemic cardiomyopathy based on RNA-Seq data , 2016, Oncotarget.

[6]  M. Hatzfeld,et al.  Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression. , 2000, Cardiovascular research.

[7]  D. Gudbjartsson,et al.  Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac Death , 2018, Circulation. Genomic and precision medicine.

[8]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[9]  Andrea Rau,et al.  Differential meta-analysis of RNA-seq data from multiple studies , 2013, BMC Bioinformatics.

[10]  K. Yutzey,et al.  Transcriptional regulation of heart valve development and disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  W. Grajkowska,et al.  Significance of low desmin expression in cardiomyocytes in patients with idiopathic dilated cardiomyopathy. , 2013, The American journal of cardiology.

[12]  Kazuwa Nakao,et al.  Transcriptional regulation of the fetal cardiac gene program. , 2012, Journal of pharmacological sciences.

[13]  I. Moskowitz,et al.  TBX5: A Key Regulator of Heart Development. , 2017, Current topics in developmental biology.

[14]  Marcel Martin Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[15]  Eric D Wieben,et al.  Recessive MYH6 Mutations in Hypoplastic Left Heart With Reduced Ejection Fraction , 2015, Circulation. Cardiovascular genetics.

[16]  T. Thum,et al.  Hallmarks of ion channel gene expression in end‐stage heart failure , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Cotrufo,et al.  Desmin‐free cardiomyocytes and myocardial dysfunction in end stage heart failure , 2004, European journal of heart failure.

[18]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[19]  L. Mestroni,et al.  Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure , 2018, BMC Genomics.

[20]  B. Bruneau,et al.  Tbx5-dependent pathway regulating diastolic function in congenital heart disease , 2008, Proceedings of the National Academy of Sciences.

[21]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[22]  E. A. Packham,et al.  Physical Interaction between TBX5 and MEF2C Is Required for Early Heart Development , 2009, Molecular and Cellular Biology.

[23]  U. de Faire,et al.  Retrospective Analysis of Coagulation Factor II Receptor (F2R) Sequence Variation and Coronary Heart Disease in Hypertensive Patients , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[25]  M. Crackower,et al.  Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.

[26]  S. Scherer,et al.  Rare Copy Number Variants Contribute to Congenital Left-Sided Heart Disease , 2012, PLoS genetics.

[27]  Wei Zhang,et al.  Association of single nucleotide polymorphisms in the 3′UTR region of TPM1 gene with dilated cardiomyopathy , 2019, Medicine.

[28]  M. Asakura,et al.  Global gene expression profiling in the failing myocardium. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[29]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[30]  Christoph D. Rau,et al.  WIPI1 is a conserved mediator of right ventricular failure. , 2019, JCI insight.

[31]  Shiaulou Yuan,et al.  Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. , 2013, Journal of molecular and cellular cardiology.

[32]  K. Boheler,et al.  Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. , 1990, The Journal of clinical investigation.

[33]  Wei Sun,et al.  Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells. , 2015, Journal of the American College of Cardiology.

[34]  Michael W Kattan,et al.  Meta-analysis: Its strengths and limitations. , 2008, Cleveland Clinic journal of medicine.

[35]  T. Morisaki,et al.  The role of a common TNNT2 polymorphism in cardiac hypertrophy , 2004, Journal of Human Genetics.

[36]  A. Rosenwald,et al.  The 140-kD isoform of CD56 (NCAM1) directs the molecular pathogenesis of ischemic cardiomyopathy. , 2013, The American journal of pathology.

[37]  A. Hamsten,et al.  Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels , 2009, Thrombosis and Haemostasis.

[38]  Francisco Azuaje,et al.  Identification of dilated cardiomyopathy signature genes through gene expression and network data integration. , 2008, Genomics.

[39]  F. Conlon,et al.  Emerging Field of Cardiomics: High-Throughput Investigations into Transcriptional Regulation of Cardiovascular Development and Disease. , 2016, Trends in genetics : TIG.

[40]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[41]  L. D. de Windt,et al.  Regulation of fetal gene expression in heart failure. , 2013, Biochimica et biophysica acta.

[42]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[43]  G. Ewald,et al.  Deep RNA Sequencing Reveals Dynamic Regulation of Myocardial Noncoding RNAs in Failing Human Heart and Remodeling With Mechanical Circulatory Support , 2014, Circulation.

[44]  V. Roger Epidemiology of Heart Failure , 2013, Circulation research.

[45]  P. Munroe,et al.  Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets , 2020, Genes.

[46]  Yujie Zhou,et al.  Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease , 2017, Cardiovascular Diabetology.

[47]  Fei Li,et al.  Excretion of Urinary Orosomucoid 1 Protein Is Elevated in Patients with Chronic Heart Failure , 2014, PloS one.

[48]  Pamela R. Fain,et al.  α-Myosin Heavy Chain: A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy , 2005 .

[49]  R. Young,et al.  Transcriptional Regulation and Its Misregulation in Disease , 2013, Cell.

[50]  J Michael DiMaio,et al.  Making steady progress on direct cardiac reprogramming toward clinical application. , 2013, Circulation research.

[51]  F. Müller,et al.  Transcriptional regulation by cAMP in the heart , 2000, Molecular and Cellular Biochemistry.

[52]  M. Kendall Statistical Methods for Research Workers , 1937, Nature.

[53]  Hanbo Chen,et al.  VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R , 2011, BMC Bioinformatics.

[54]  K. Nakayama,et al.  Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. , 2008, Cardiovascular research.

[55]  X. Li,et al.  Deep RNA sequencing elucidates microRNA-regulated molecular pathways in ischemic cardiomyopathy and nonischemic cardiomyopathy. , 2016, Genetics and molecular research : GMR.

[56]  J. Pankow,et al.  Five common gene variants identify elevated genetic risk for coronary heart disease , 2007, Genetics in Medicine.

[57]  E. Roselló-Lletí,et al.  Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy , 2015, BMC Medical Genomics.